NIDO-361

N/A

Report date: 2025/05/14 16:59:30
NME

Base Information

Drug NameNIDO-361
Drug Alias NameNIDO-361
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor modulators
TargetsAndrogen Receptor
Therapy Area/IndicationsBulbo-Spinal Atrophy, X-Linked
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyDenmarkAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNido Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNido Biosciences Inc
Inactive CompaniesN/A
Active IndicationsBulbo-Spinal Atrophy, X-Linked
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A